J. Scott Garland

EVP & Chief Commerical Officer, Exelixis.

Companies

Enliven Therapeutics, Inc.Board member Jan 9, 2026 to now¹
LB PHARMACEUTICALS INCBoard member Sep 10, 2025 to now²
Olema Pharmaceuticals, Inc.Board member Oct 17, 2023 to now³
ALX ONCOLOGY HOLDINGS INCBoard member Nov 29, 2022 to now⁴
Day One Biopharmaceuticals, Inc.Board member Aug 18, 2021 to now⁵
Calithera Biosciences, Inc.Board member Jul 14, 2020 to Jun 3, 2022⁶
Karyopharm Therapeutics Inc.Board member Nov 12, 2014 to Jun 7, 2019⁷
ExelixisEVP & Chief Commerical Officer Oct 24, 2011 to Sep 19, 2013⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREnliven Therapeutics, Inc., Board member
2
SEC EDGARLB PHARMACEUTICALS INC, Board member
3
SEC EDGAROlema Pharmaceuticals, Inc., Board member
4
SEC EDGARALX ONCOLOGY HOLDINGS INC, Board member
5
SEC EDGARDay One Biopharmaceuticals, Inc., Board member
6
SEC EDGARCalithera Biosciences, Inc., Board member
7
SEC EDGARKaryopharm Therapeutics Inc., Board member
8
SEC EDGARExelixis, EVP & Chief Commerical Officer